4.1 Review

The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients: Part 1

Journal

UROLOGIA INTERNATIONALIS
Volume 100, Issue 3, Pages 263-270

Publisher

KARGER
DOI: 10.1159/000486138

Keywords

Urinary tract infection; Cystitis; Pyelonephritis; Diagnosis; Systematic review; Clinical guideline

Funding

  1. Leo Pharma
  2. Astellas
  3. Monika Kutzner Stiftung
  4. Pfizer
  5. Bionorica
  6. Daiichi Sanchyo
  7. MerLion
  8. OM-Pharma
  9. Rosen Pharma
  10. Zambon
  11. Basilea
  12. Enteris
  13. Helperby
  14. Rosen-Pharma
  15. Akademie der Deutschen Urologen
  16. CGC Cramer
  17. Fischerappelt
  18. Fresenius
  19. Gilead
  20. Infectopharm
  21. MDS
  22. MedConcept
  23. MIM-Verlag
  24. Omega/Abtei
  25. Pfleger
  26. Springer-Verlag
  27. Strathmann Thieme-Verlag
  28. Uromed
  29. Achaogen
  30. AstraZeneca
  31. Cubist
  32. Galenus
  33. MSD
  34. Pierre Fabre
  35. Pierelle Research
  36. Calixa
  37. DFG
  38. Europ. Ass. f. Urologie
  39. Hess. Minist. f. Wirtschaft und Kunst

Ask authors/readers for more resources

Objectives: We aimed to update the 2010 evidence- and consensus-based national clinical guideline on the diagnosis and management of uncomplicated urinary tract infections (UTIs) in adult patients. Materials and Methods: An interdisciplinary group consisting of 17 representatives of 12 medical societies and a patient representative was formed. Systematic literature searches were conducted in MEDLINE, EMBASE, and the Cochrane Library to identify literature published in 2010-2015. Results: We provide 75 recommendations and 68 statements in the updated evidence- and consensus-based national clinical guideline. The diagnostics part covers practical recommendations on cystitis and pyelonephritis for each defined patient group. Clinical examinations, as well as laboratory testing and microbiological pathogen assessment, are addressed. Conclusion: In accordance with the global antibiotic stewardship initiative and considering new insights in scientific research, we updated our German clinical UTI guideline to promote a responsible antibiotic use and to give clear hands-on recommendations for the diagnosis and management of UTIs in adults in Germany for healthcare providers and patients. (c) 2018 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available